International Biotechnology (LON:IBT) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?

International Biotechnology (LON:IBT – Get Free Report) crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of GBX 1,022.90 and traded as high as GBX 1,120. International Biotechnology shares last traded at GBX 1,105, with a volume of 89,639 shares traded.

International Biotechnology Stock Performance

The company has a market capitalization of £349.77 million, a P/E ratio of 4.57 and a beta of 0.46. The stock’s fifty day moving average price is GBX 1,098.40 and its 200-day moving average price is GBX 1,022.90. The company has a debt-to-equity ratio of 9.43, a quick ratio of 0.32 and a current ratio of 0.11.

International Biotechnology Company Profile

(Get Free Report)

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.

Further Reading

Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.